Analyze Diet
New Zealand veterinary journal2005; 50(4); 140-147; doi: 10.1080/00480169.2002.36300

Equine respiratory viruses in foals in New Zealand.

Abstract: To identify the respiratory viruses that are present among foals in New Zealand and to establish the age at which foals first become infected with these viruses. Methods: Foals were recruited to the study in October/ November 1995 at the age of 1 month (Group A) or in March/ April 1996 at the age of 4-6 months (Groups B and C). Nasal swabs and blood samples were collected at monthly intervals. Nasal swabs and peripheral blood leucocytes (PBL) harvested from heparinised blood samples were used for virus isolation; serum harvested from whole-blood samples was used for serological testing for the presence of antibodies against equine herpesvirus (EHV)-1 or -4, equine rhinitis-A virus (ERAV), equine rhinitis-B virus (ERBV), equine adenovirus 1 (EAdV-1), equine arteritis virus (EAV), reovirus 3 and parainfluenza virus type 3 (PIV3). Twelve foals were sampled until December 1996; the remaining 19 foals were lost from the study at various times prior to this date. Results: The only viruses isolated were EHV-2 and EHV-5. EHV-2 was isolated from 155/157 PBL samples collected during the period of study and from 40/172 nasal swabs collected from 18 foals. All isolations from nasal swabs, except one, were made over a period of 2-4 months from January to April (Group A), March to April (Group B) or May to July (Group C). EHV-5 was isolated from either PBL, nasal swabs, or both, from 15 foals on 32 occasions. All foals were positive for antibodies to EHV-1 or EHV-4, as tested by serum neutralisation (SN), on at least one sampling occasion and all but one were positive for EHV-1 antibodies measured by enzyme-linked immunosorbent assay (ELISA) on at least one sampling occasion. Recent EHV-1 infection was evident at least once during the period of study in 18/23 (78%) foals for which at least two samples were collected. SN antibodies to ERBV were evident in 19/23 (83%) foals on at least one sampling occasion and 15/23 foals showed evidence of seroconversion to ERBV. Antibodies to ERAV were only detected in serum samples collected from foals in Group A and probably represented maternally-derived antibodies. Haemagglutination inhibition (HI) antibody titres 1:10 to EAdV-1were evident in 21/23 (91%) foals on at least one sampling occasion and 16/23 foals showed serological evidence of recent EAdV-1 infection. None of the 67 serum samples tested were positive for antibodies to EAV, reovirus 3 or PIV3. There was no clear association between infection with any of the viruses isolated or tested for and the presence of overt clinical signs of respiratory disease. Conclusions: There was serological and/or virological evidence that EHV-1, EHV-2, EHV-5, EAdV-1 and ERBV infections were present among foals in New Zealand. EHV-2 infection was first detected in foals as young as 3 months of age. The isolation of EHV-2 from nasal swabs preceded serological evidence of infection with other respiratory viruses, suggesting that EHV-2 may predispose foals to other viral infections.
Publication Date: 2005-07-21 PubMed ID: 16032260DOI: 10.1080/00480169.2002.36300Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the respiratory viruses prevalent among foals in New Zealand and the age at which these foals first contract these viruses. The study found Equine herpesvirus (EHV)-1, EHV-2, EHV-5, equine adenovirus 1 (EAdV-1), and equine rhinitis-B virus (ERBV) among the foals with EHV-2 detected as early as 3 months of age.

Research Methodology

  • The study was carried out on foals in October/November 1995 at 1 month of age (Group A), or in March/April 1996 at the age of 4-6 months (Groups B and C).
  • Nasal swabs, blood samples and peripheral blood leucocytes (PBL) harvested from heparinised blood samples were taken for virus isolation.
  • Serum harvested from whole-blood samples was used for serological testing against various viruses.
  • Twelve foals were observed until December 1996; 19 foals dropped out of the study before this date.

Results

  • The only viruses isolated were EHV-2 and EHV-5, with EHV-2 found in most PBL samples and several nasal swabs collected.
  • Most isolations from nasal swabs occurred over a period of 2-4 months from January to April (Group A), March to April (Group B) or May to July (Group C).
  • All the foals tested positive for antibodies to EHV-1 or EHV-4 on at least one sampling occasion and almost all were positive for EHV-1 antibodies measured by enzyme linked immunosorbent assay (ELISA) on at least one sampling occasion.
  • Most foals showed serological evidence of recent EHV-1 infection. Antibodies to equine rhinitis-A virus (ERAV) were only detected in the foals in Group A and are likely maternally-derived antibodies.
  • Antibodies to EAdV-1 were evident in most foals, and many showed serological evidence of recent EAdV-1 infection.
  • No serum sample tested positive for antibodies to equine arteritis virus (EAV), reovirus 3 or parainfluenza virus type 3 (PIV3).
  • No clear link was established between the detected viral infection and overt clinical signs of respiratory disease.

Conclusion

  • The study found serological or virological evidence of EHV-1, EHV-2, EHV-5, EAdV-1 and ERBV infections among foals in New Zealand.
  • EHV-2 infection was first detected in foals as young as 3 months of age.
  • The isolation of EHV-2 from nasal swabs occurred before serological evidence of infection with other respiratory viruses, suggesting that EHV-2 may predispose foals to other viral infections.

Cite This Article

APA
Dunowska M, Wilks CR, Studdert MJ, Meers J. (2005). Equine respiratory viruses in foals in New Zealand. N Z Vet J, 50(4), 140-147. https://doi.org/10.1080/00480169.2002.36300

Publication

ISSN: 0048-0169
NlmUniqueID: 0021406
Country: England
Language: English
Volume: 50
Issue: 4
Pages: 140-147

Researcher Affiliations

Dunowska, M
  • Institute of Veterinary Animal and Biomedical Sciences, Massey University, Private Bag 11222, Palmerston North, New Zealand. mdunowsk@lamat.colostate.edu
Wilks, C R
    Studdert, M J
      Meers, J

        Citations

        This article has been cited 18 times.
        1. Stasiak K, Dunowska M, Rola J. Genetic Diversity of Equid Herpesvirus 5 in Temporal Samples from Mares and Their Foals at Three Polish National Studs. Int J Mol Sci 2025 Aug 27;26(17).
          doi: 10.3390/ijms26178298pubmed: 40943220google scholar: lookup
        2. Wondimagegnehu K, Leta S, Amenu K, Negussie H. Molecular detection and assessment of the epidemiological risk factors associated with equine herpesvirus 2 and 5 in working equids in central Ethiopia. Vet Med Sci 2022 Nov;8(6):2396-2403.
          doi: 10.1002/vms3.925pubmed: 36063540google scholar: lookup
        3. Stasiak K, Dunowska M, Rola J. Kinetics of the Equid Herpesvirus 2 and 5 Infections among Mares and Foals from Three Polish National Studs. Viruses 2022 Mar 29;14(4).
          doi: 10.3390/v14040713pubmed: 35458443google scholar: lookup
        4. Lee SK, Choi J, Yoon J, Jung J, Park JY, Park J, Kim Y, Park JY, Park D. Molecular Detection of Equine Adenovirus 1 in Nasal Swabs from Horses in the Republic of Korea. Vet Sci 2022 Apr 13;9(4).
          doi: 10.3390/vetsci9040187pubmed: 35448685google scholar: lookup
        5. Temesgen T, Getachew Y, Negussie H. Molecular Identification of Equine Herpesvirus 1, 2, and 5 in Equids with Signs of Respiratory Disease in Central Ethiopia. Vet Med (Auckl) 2021;12:337-345.
          doi: 10.2147/VMRR.S339042pubmed: 34956854google scholar: lookup
        6. El-Hage C, Mekuria Z, Dynon K, Hartley C, McBride K, Gilkerson J. Association of Equine Herpesvirus 5 with Mild Respiratory Disease in a Survey of EHV1, -2, -4 and -5 in 407 Australian Horses. Animals (Basel) 2021 Nov 30;11(12).
          doi: 10.3390/ani11123418pubmed: 34944194google scholar: lookup
        7. Scheurer L, Bachofen C, Hardmeier I, Lechmann J, Schoster A. Prevalence of Nasal Shedding of Equid Gammaherpesviruses in Healthy Swiss Horses. Viruses 2021 Aug 25;13(9).
          doi: 10.3390/v13091686pubmed: 34578268google scholar: lookup
        8. Thorsteinsdóttir L, Jónsdóttir S, Stefánsdóttir SB, Andrésdóttir V, Wagner B, Marti E, Torsteinsdóttir S, Svansson V. The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response. PLoS One 2019;14(6):e0218576.
          doi: 10.1371/journal.pone.0218576pubmed: 31226153google scholar: lookup
        9. Dall Agnol AM, Beuttemmuller EA, Pilz D, Leme RA, Saporiti V, Headley SA, Alfieri AF, Alfieri AA. Detection of Equid gammaherpesvirus 2 and 5 DNA in the upper respiratory tract of asymptomatic horses from Southern Brazil. Braz J Microbiol 2019 Jul;50(3):875-878.
          doi: 10.1007/s42770-019-00100-7pubmed: 31187445google scholar: lookup
        10. Van Cleemput J, Poelaert KCK, Laval K, Nauwynck HJ. Unravelling the first key steps in equine herpesvirus type 5 (EHV5) pathogenesis using ex vivo and in vitro equine models. Vet Res 2019 Feb 18;50(1):13.
          doi: 10.1186/s13567-019-0630-6pubmed: 30777128google scholar: lookup
        11. Marenzoni ML, Stefanetti V, Danzetta ML, Timoney PJ. Gammaherpesvirus infections in equids: a review. Vet Med (Auckl) 2015;6:91-101.
          doi: 10.2147/VMRR.S39473pubmed: 30155436google scholar: lookup
        12. Stasiak K, Dunowska M, Rola J. Prevalence and sequence analysis of equid herpesviruses from the respiratory tract of Polish horses. Virol J 2018 Jul 11;15(1):106.
          doi: 10.1186/s12985-018-1018-3pubmed: 29996858google scholar: lookup
        13. Costantini D, Seeber PA, Soilemetzidou SE, Azab W, Bohner J, Buuveibaatar B, Czirják GÁ, East ML, Greunz EM, Kaczensky P, Lamglait B, Melzheimer J, Uiseb K, Ortega A, Osterrieder N, Sandgreen DM, Simon M, Walzer C, Greenwood AD. Physiological costs of infection: herpesvirus replication is linked to blood oxidative stress in equids. Sci Rep 2018 Jul 9;8(1):10347.
          doi: 10.1038/s41598-018-28688-0pubmed: 29985431google scholar: lookup
        14. Smith FL, Watson JL, Spier SJ, Kilcoyne I, Mapes S, Sonder C, Pusterla N. Frequency of shedding of respiratory pathogens in horses recently imported to the United States. J Vet Intern Med 2018 Jul;32(4):1436-1441.
          doi: 10.1111/jvim.15145pubmed: 29761571google scholar: lookup
        15. Junkkari R, Simojoki H, Heiskanen ML, Pelkonen S, Sankari S, Tulamo RM, Mykkänen A. A comparison of unheated loose housing with stables on the respiratory health of weaned-foals in cold winter conditions: an observational field-study. Acta Vet Scand 2017 Oct 26;59(1):73.
          doi: 10.1186/s13028-017-0339-3pubmed: 29073941google scholar: lookup
        16. Woo PC, Lau SK, Choi GK, Huang Y, Wernery R, Joseph S, Wong EY, Elizabeth SK, Patteril NA, Li T, Wernery U, Yuen KY. Equine rhinitis B viruses in horse fecal samples from the Middle East. Virol J 2016 Jun 7;13:94.
          doi: 10.1186/s12985-016-0547-xpubmed: 27267372google scholar: lookup
        17. Houtsma A, Bedenice D, Pusterla N, Pugliese B, Mapes S, Hoffman AM, Paxson J, Rozanski E, Mukherjee J, Wigley M, Mazan MR. Association between inflammatory airway disease of horses and exposure to respiratory viruses: a case control study. Multidiscip Respir Med 2015;10:33.
          doi: 10.1186/s40248-015-0030-3pubmed: 26535117google scholar: lookup
        18. Marenzoni ML, Coppola G, Maranesi M, Passamonti F, Cappelli K, Capomaccio S, Verini Supplizi A, Thiry E, Coletti M. Age-dependent prevalence of equid herpesvirus 5 infection. Vet Res Commun 2010 Dec;34(8):703-8.
          doi: 10.1007/s11259-010-9443-9pubmed: 20842426google scholar: lookup